An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.

Abstract excerpt

Elucidating the molecular drivers of human breast cancers requires a strategy that is capable of integrating multiple forms of data and an ability to interpret the functional consequences of a given genetic aberration. Here we present an integrated genomic strategy based on the use of gene expression signatures of oncogenic pathway activity (n = 52) as a framework to analyze DNA copy number alterations in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cluster Analysis
• Share to DNA Copy Number Variations